ANI Pharma Inc (28) | Business Finance (9)

Browse by Subcategory

Recent Contracts

Asset Purchase Agreement between Holmdel Pharmaceuticals, LP and ANI Pharmaceuticals, Inc (Filed With SEC on May 10, 2022)
Underwriting Agreement, dated November 3, 2021, between ANI Pharmaceuticals, Inc. and Guggenheim Securities, LLC (Filed With SEC on November 4, 2021)
Equity Commitment and Investment Agreement dated March 8, 2021 by and between ANI Pharmaceuticals, Inc. and Ampersand 2020 Limited Partnership (Filed With SEC on March 9, 2021)
Inducement Stock Option Award Agreement, effective as of September 8, 2020, between ANI Pharmaceuticals, Inc. and Nikhil Lalwani (Filed With SEC on November 5, 2020)
Asset Purchase Agreement between Cranford Pharmaceuticals, LLC and ANI Pharmaceuticals, Inc (Filed With SEC on May 10, 2022)
Asset Purchase Agreement between Amerigen Pharmaceuticals LTD. and ANI Pharmaceuticals, Inc (Filed With SEC on February 27, 2020)
Form of Restricted Stock Grant Agreement (Filed With SEC on February 27, 2020)
Form of Non- Statutory Stock Option Agreement (Filed With SEC on February 27, 2020)
Amendment No. 4 to Asset Purchase Agreement between ANI Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc (Filed With SEC on May 9, 2019)